Diagnosis and Management of Children With Tuberous Sclerosis Complex

Celia Dewell1, Denise L Chan1,2, Vanessa Sarkozy1,2

  • 1Tuberous Sclerosis Complex Management Clinic, Sydney Children's Hospital, Sydney, Australia.

Insights

Tuberous sclerosis complex (TSC) is a genetic disorder affecting multiple organs. Early diagnosis and multidisciplinary care, including precision medicine, can significantly improve outcomes for patients with TSC.

Area of Science:

  • Genetics and Medicine
  • Neurology
  • Pediatrics

Background:

  • Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by variants in TSC1 or TSC2 genes.
  • It presents with benign tumors (hamartomas) in various organs and neurological complications like epilepsy and developmental disabilities.
  • TSC affects multiple systems, including the brain, kidneys, skin, and heart, with variable onset and severity.

Purpose of the Study:

  • To describe a multidisciplinary model of care for Tuberous Sclerosis Complex (TSC).
  • To emphasize early detection, diagnosis, and active surveillance of seizures in TSC.
  • To outline lifelong management guidelines for TSC-specific manifestations.

Main Methods:

  • Review of clinical presentation, diagnosis, and genetic basis of TSC.
  • Discussion of genetic counseling's role in TSC management.
  • Emphasis on surveillance and management strategies for TSC-related issues.

Main Results:

  • TSC necessitates a multidisciplinary approach for comprehensive patient care.
  • Early diagnosis and intervention, including precision medicine (mTOR inhibitors), can mitigate disease burden.
  • Active surveillance and management of seizures are crucial for affected children.

Conclusions:

  • A structured, multidisciplinary model of care is essential for optimizing outcomes in Tuberous Sclerosis Complex.
  • Lifelong surveillance and tailored management of neurological, developmental, and organ-specific issues are critical.
  • Precision medicine offers targeted therapeutic options for epilepsy and tumors in TSC.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
461
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
516
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
434